RNAi

Roche pays $200M for rights to Dicerna's hepatitis B RNAi drug
Fierce Biotech
Thu, 10/31/19 - 10:29 am
Roche
Dicerna Pharmaceuticals
RNAi
hepatitis B
DCR-HBVS
Alnylam's Onpattro back in the game against Ionis, thanks to NICE U-turn
Fierce Pharma
Tue, 07/9/19 - 06:32 pm
Ionis
Tegsedi
RNAi
Alnylam
Onpattro
NICE
RNAi Therapeutics Focused Sirnaomics Closes $47 Million Series C Round
CP Wire
Fri, 04/26/19 - 10:06 am
Sriaomics
STP705
cholangiocarcinoma
hepatocellular carcinoma
RNAi
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases
Xconomy
Mon, 04/8/19 - 09:56 am
Alnylam
Regeneron
RNAi
eye health
brain diseases
After landing a historic FDA OK, Alnylam chief John Maraganore scores a big raise
Endpoints
Fri, 03/22/19 - 10:11 pm
Alnylam
RNAi
Pharma CEOs
John Maraganore
exective pay
Data in Hand, Alnylam To Seek OK For Second RNAi Drug
Xconomy
Wed, 03/6/19 - 10:07 am
Alnylam
RNAi
FDA
acute hepatic porphyria
givosiran
Here's Why Arrowhead Pharmaceuticals Shot 237.5% Higher in 2018
Motley Fool
Sun, 01/13/19 - 11:36 am
Arrowhead Pharmaceuticals
RNAi
Alnylam CEO talks politics, gene therapy and not becoming Pfizer
BioPharma Dive
Sun, 12/16/18 - 12:12 am
Alnylam
RNAi
Onpattro
Pharma CEOs
John Maraganore
Here's Why Arrowhead Pharmaceuticals Jumped 14.1% in November
Motley Fool
Mon, 12/10/18 - 07:04 pm
Arrowhead Pharmaceuticals
ARO-HBV
hepatitis B
Janssen
RNAi
Alnylam's Onpattro sales look 'disappointing' in early days of RNAi launch: analyst
Fierce Pharma
Mon, 11/19/18 - 11:31 am
Alnylam
RNAi
Onpattro
hATTR amyloidosis
Alnylam seeks MHRA approval to start ALN-AAT02 phase 1/2 trial
Pharmaceutical Business Review
Thu, 10/4/18 - 06:55 pm
Alnylam
RNAi
ALN-AAT02
MHRA
UK
Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug
Fierce Biotech
Thu, 10/4/18 - 10:22 am
JNJ
Arrowhead
hepatitis B
RNAi
RNAi company Dicerna raises $100M follow-on
BioCentury
Fri, 09/7/18 - 05:47 pm
Dicerna Pharmaceuticals
RNAi
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
Xconomy
Thu, 08/30/18 - 10:20 am
RNAi
Alynylam
Europe
Onpattro
hATTR
Patisiran
Sirnaomics cleared to start first trial of RNAi lead in cancer
Fierce Biotech
Sat, 08/18/18 - 05:14 pm
gene silencing
Simaomics
RNAi
STP705
3 Hurdles Ahead of Alnylam and Its Revolutionary New Drug
Motley Fool
Wed, 08/15/18 - 10:13 pm
Alnylam
Onpattro
RNAi
After Alnylam’s solo maiden launch, here comes the tricky bit
EP Vantage
Tue, 08/14/18 - 12:06 am
Alnylam
drug launches
FDA
RNAi
Patisiran
Onpattro
In first, FDA approves RNA interference drug from Alnylam
Biopharma Dive
Fri, 08/10/18 - 02:25 pm
Alnylam
RNAi
FDA
Patisiran
Onpattro
hATTR amyloidosis
With patisiran launch in its sights, Alnylam plots a major hiring spree
Fierce Pharma
Tue, 08/7/18 - 12:02 pm
Alnylam
Patisiran
RNAi
hirings
Focused on rebuilding the pipeline, Axovant’s new crew assembles another preclinical gene therapy deal
Endpoints
Mon, 07/9/18 - 10:55 am
Axovant Sciences
AXO-Lenti-PD
gene therapy
RNAi
Benitec

Pages